Literature DB >> 31041798

Thrombotic Complications in Gliomas.

Alexandra L Czap1, Ashley Becker1, Patrick Y Wen2.   

Abstract

Arterial and venous thromboses are common in glioma patients, both in the perioperative period and throughout the course of the disease. High-grade glioma patients harbor underlying hypercoagulability, which predisposes these high-risk patients with prolonged immobility and neurologic deficits to thrombotic events. Despite the high incidence and recurrent nature of these complications, there is no standardized approach to the management of glioma patients, and many challenges remain. Historically, the perceived risk of intracranial and intratumoral hemorrhage limited the use of anticoagulation, favoring nonpharmacological prophylaxis and treatment. Multiple studies have demonstrated the safety and efficacy of anticoagulation when indicated, with low molecular weight heparin as the preferred short- or long-term treatment. This review will discuss the epidemiology, risk factors, and therapeutic management of both venous and arterial thrombotic complications in glioma. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31041798     DOI: 10.1055/s-0039-1687892

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  4 in total

Review 1.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

2.  Systemic coagulation is activated in patients with meningioma and glioblastoma.

Authors:  Swaroopa Yerrabothala; Brett L Gourley; James C Ford; Syed Rakin Ahmed; Stephen J Guerin; Marc Porter; Heather A Wishart; Marc S Ernstoff; Camilo E Fadul; Deborah L Ornstein
Journal:  J Neurooncol       Date:  2021-10-15       Impact factor: 4.130

3.  Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma.

Authors:  Fleur H J Kaptein; Milou A M Stals; Maaike Y Kapteijn; Suzanne C Cannegieter; Linda Dirven; Sjoerd G van Duinen; Ronald van Eijk; Menno V Huisman; Eva E Klaase; Martin J B Taphoorn; Henri H Versteeg; Jeroen T Buijs; Johan A F Koekkoek; Frederikus A Klok
Journal:  J Thromb Haemost       Date:  2022-05-09       Impact factor: 16.036

4.  Neutrophil extracellular traps induce a hypercoagulable state in glioma.

Authors:  Shihua Zhang; Mengfan Guo; Qianzi Liu; Jingfeng Liu; Yankun Cui
Journal:  Immun Inflamm Dis       Date:  2021-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.